Verapamil hydrochloride is the hydrochloride form of Verapamil, that is a phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. It is grouped under the following drug class(es): Antianginals and Calcium Channel Blockers. Its therapeutic use is listed as antihypertensives, cardiovascular and migraine preventive agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Verelan and Covera. Its PubChem CID is 62969.
Verapamil hydrochloride
| CAS No | 152-11-4 |
|---|---|
| Molecular Formula | C27H39ClN2O4 |
| Molecular Weight | 491.1 g/mol |
| Synonyms | 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Verapamil hydrochloride is the hydrochloride form of Verapamil, that is a phenylalkylamine calcium channel blocking agent.
The listed CAS number is 152-11-4.
The listed molecular formula is C27H39ClN2O4.
The listed molecular weight is 491.1 g/mol.
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride.
The source lists Verelan and Covera.